Has Michael Lloyd, MD received payments from drug or device companies?

Yes. Drug and device makers reported $221,390 in general payments to Michael Lloyd, MD across 369 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Michael Lloyd, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Michael Lloyd, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Michael Lloyd, MD

Clinical Cardiac Electrophysiology · Atlanta, GANPI 1992722821

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (54.3%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 9 manufacturers reported payments, led by Boston Scientific at 48.2% of the total. Reporting peaked in 2022 at $57,036 and has fallen 51.1% since, to $27,913 in 2025. Among clinical cardiac electrophysiology clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$221,390in general payments, 2019–2025

Across 369 payments — averaging $599.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Boston Scientific$107K
Medtronic$87K
Abbott$11K
Biosense Webster, Inc.$10K
Medical Device Business Services, Inc.$3K
Circa Scientific, Inc.$2K
plus $818 from 3 others

$222,346in research payments, 2019–2025

Across 87 payments — averaging $2555.70 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Medtronic$147K
Abbott$70K
Boston Scientific$6K

What the payments were for

Consulting fees$58,18326%
Speaking & faculty fees$120,14954%
Travel & lodging$34,57616%
Food & beverage$8,4824%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Boston Scientific	143	$106,681
Medtronic(2 entities)	150	$87,399
Abbott	56	$11,104
Biosense Webster, Inc.	11	$10,211
Medical Device Business Services, Inc.	3	$2,700
Circa Scientific, Inc.	1	$2,476
Biotronik Inc.	2	$719
Cardiva Medical, Inc.	2	$54
Cardiofocus, Inc.	1	$45

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Micra$58,857
VersaCross Access Solution$25,619
CLINICAL TRIAL PRODUCT$22,988
GENERAL - THERAPIES$12,753
LITHOVUE EMPOWER$3,740
EMBLEM MRI S-ICD$3,586
ENSITE$3,324
ENSITE PRECISION$2,628
QUADRA ASSURA$2,100
Carto 3$1,907
AVEIR$1,705
VersaCross Connect LAAC Access Solution$1,173
Carto 3 System$900
S-ICD System Magnet$500
EVERA MRI XT DR SURESCAN$371
Arctic Front$231
Attain$148

How this compares

$221,390 in reported general payments places this provider in the 95th percentile of 93 clinical cardiac electrophysiology providers in Georgia.

See all clinical cardiac electrophysiology providers in Georgia →

Medicare billing

Part B allowed, 2024

$285,832

Medicare patients

2,391

Services billed

5,390

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	579	$664,835
XareltoRivaroxaban	190	$206,111
Dofetilide	102	$32,685
MultaqDronedarone Hcl	17	$16,971
EntrestoSacubitril/Valsartan	18	$14,354
Flecainide Acetate	245	$11,301
JardianceEmpagliflozin	11	$7,130
Metoprolol Succinate	370	$5,075
Propafenone Hcl ErPropafenone Hcl	20	$3,816
Nadolol	33	$2,577
SotalolSotalol Hcl	140	$2,533
Mexiletine Hcl	14	$1,817
Omega-3 Acid Ethyl Esters	11	$1,133
Amiodarone Hcl	52	$930
Potassium Chloride	40	$840

Paid to pharmacies, not to this prescriber.

Other clinical cardiac electrophysiology in Atlanta

David DelurgioAtlanta$695K
Thomas DeeringAtlanta$237K
Mikhael El-ChamiAtlanta$172K
Sandeep GoyalAtlanta$153K
Bruce StamblerAtlanta$91K
Stacy WestermanAtlanta$60K
Ashish BhimaniAtlanta$51K
Aaron RichardsonAtlanta$51K
Devinder DhindsaAtlanta$47K
Ahmadreza KarimianpourAtlanta$41K

See the full list for Georgia →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →